138 related articles for article (PubMed ID: 30214603)
1. Thiopurine methyltransferase activity in children with acute myeloid leukemia.
Sobiak J; Skalska-Sadowska J; Chrzanowska M; Resztak M; Kołtan S; Wysocki M; Wachowiak J
Oncol Lett; 2018 Oct; 16(4):4699-4706. PubMed ID: 30214603
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
3. [The effect of the adverse events with thiopurine S-methyltransferase gene mutation on outcome of childhood acute lymphoblastic leukemia].
Cao L; Zhang ZX; Chai YH; Hu SY; Wang Y; Zhao WL; He HL; Lu J
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):247-52. PubMed ID: 23683426
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia.
Linga VG; Patchva DB; Mallavarapu KM; Tulasi V; Kalpathi KI; Pillai A; Gundeti S; Rajappa SJ; Digumarti R
Indian J Med Paediatr Oncol; 2014 Oct; 35(4):276-80. PubMed ID: 25538405
[TBL] [Abstract][Full Text] [Related]
5. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study.
El-Rashedy FH; Ragab SM; Dawood AA; Temraz SA
Indian J Med Paediatr Oncol; 2015; 36(4):265-70. PubMed ID: 26811598
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
Karim H; Appell ML; Fotoohi A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between single nucleotide polymorphisms in thiopurine methyltransferase gene and tolerance to thiopurines in acute leukemia].
Ma XL; Zhu P; Wu MY; Li ZG; Hu YM
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):929-33. PubMed ID: 14723818
[TBL] [Abstract][Full Text] [Related]
9. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
[TBL] [Abstract][Full Text] [Related]
10. Interference free and simplyfied liquid chromatography-based determination of thiopurine S-methyltransferase activity in erythrocytes.
Khalil MN; Erb N; Khalil PN; Escherich G; Janka-Schaub GE
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):105-11. PubMed ID: 15897017
[TBL] [Abstract][Full Text] [Related]
11. Role of TPMT and ITPA variants in mercaptopurine disposition.
Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
Lennard L; Welch JC; Lilleyman JS
Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
[TBL] [Abstract][Full Text] [Related]
13. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.
Bo J; Schrøder H; Kristinsson J; Madsen B; Szumlanski C; Weinshilboum R; Andersen JB; Schmiegelow K
Cancer; 1999 Sep; 86(6):1080-6. PubMed ID: 10491537
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia.
Kham SK; Tan PL; Tay AH; Heng CK; Yeoh AE; Quah TC
J Pediatr Hematol Oncol; 2002; 24(5):353-9. PubMed ID: 12142782
[TBL] [Abstract][Full Text] [Related]
15. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements.
Kröplin T; Fischer C; Iven H
Eur J Clin Pharmacol; 1999 Jun; 55(4):285-91. PubMed ID: 10424321
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a reliable method for thiopurine methyltransferase (TPMT) enzyme activity in human whole blood by LC-MS/MS: An application for phenotypic and genotypic correlations.
Wiwattanakul S; Prommas S; Jenjirattithigarn N; Santon S; Puangpetch A; Pakakasama S; Anurathapan U; Sukasem C
J Pharm Biomed Anal; 2017 Oct; 145():758-764. PubMed ID: 28818801
[TBL] [Abstract][Full Text] [Related]
18. Association between TPMT*3C and decreased thiopurine S-methyltransferase activity in patients with neuromyelitis optica spectrum disorders in China.
Gong X; Mei S; Li X; Li X; Zhou H; Liu Y; Zhou A; Yang L; Zhao Z; Zhang X
Int J Neurosci; 2018 Jun; 128(6):549-553. PubMed ID: 29191122
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
[TBL] [Abstract][Full Text] [Related]
20. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.
Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE
J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
